Trial
NCT03295695
PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
—
Condition
Breast Cancer
Intervention
Fluoro-D-glucose-positron Emission Tomography
Why stopped
closure of radiolaboratory
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-04